CVS Paying $36.5 Million for Overbilling Medi-Cal for Insulin Pens
CVS is paying $36.5 million for submitting false claims to the Medi-Cal program for excessive dispensing of insulin pens. A settlement pursued by California Attorney General Rob Bonta in collaboration with the United States Department of Justice with CVS Pharmacy, …
Original Source
Read the full article at Insurancejournal →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.